AIP
ANAB icon

Ameritas Investment Partners’s AnaptysBio ANAB Stock Holding History

Ameritas Investment Partners’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Buy
1,793
+299
+20% +$18.1K ﹤0.01% 1704
2026
Q1 		$82.9K Sell
1,494
-153
-9% -$8.23K ﹤0.01% 1796
2025
Q4 		$79.8K Sell
1,647
-270
-14% -$10.5K ﹤0.01% 1834
2025
Q3 		$58.7K Hold
1,917
– – ﹤0.01% 2019
2025
Q2 		$42.6K Hold
1,917
– – ﹤0.01% 2283
2025
Q1 		$35.6K Hold
1,917
– – ﹤0.01% 2288
2024
Q4 		$25.4K Hold
1,917
– – ﹤0.01% 2531
2024
Q3 		$64.2K Hold
1,917
– – ﹤0.01% 2045
2024
Q2 		$48K Buy
1,917
+405
+27% +$9.43K ﹤0.01% 2158
2024
Q1 		$34K Hold
1,512
– – ﹤0.01% 2333
2023
Q4 		$32.4K Hold
1,512
– – ﹤0.01% 2371
2023
Q3 		$27.2K Hold
1,512
– – ﹤0.01% 2407
2023
Q2 		$30.8K Hold
1,512
– – ﹤0.01% 2320
2023
Q1 		$32.9K Hold
1,512
– – ﹤0.01% 2222
2022
Q4 		$38K Hold
1,512
– – ﹤0.01% 2248
2022
Q3 		$38K Hold
1,512
– – ﹤0.01% 2167
2022
Q2 		$30K Hold
1,512
– – ﹤0.01% 2306
2022
Q1 		$37K Hold
1,512
– – ﹤0.01% 2232
2021
Q4 		$53K Sell
1,512
-300
-17% -$9.51K ﹤0.01% 2089
2021
Q3 		$49K Hold
1,812
– – ﹤0.01% 2160
2021
Q2 		$47K Hold
1,812
– – ﹤0.01% 2215
2021
Q1 		$39K Sell
1,812
-285
-14% -$7.19K ﹤0.01% 2223
2020
Q4 		$45K Hold
2,097
– – ﹤0.01% 2048
2020
Q3 		$31K Hold
2,097
– – ﹤0.01% 2134
2020
Q2 		$47K Hold
2,097
– – ﹤0.01% 1862
2020
Q1 		$30K Hold
2,097
– – ﹤0.01% 1936
2019
Q4 		$34K Hold
2,097
– – ﹤0.01% 2122
2019
Q3 		$73K Hold
2,097
– – ﹤0.01% 1654
2019
Q2 		$118K Buy
2,097
+349
+20% +$25.1K 0.01% 1390
2019
Q1 		$128K Buy
1,748
+115
+7% +$7.94K 0.01% 1319
2018
Q4 		$104K Hold
1,633
– – 0.01% 1346
2018
Q3 		$163K Hold
1,633
– – 0.01% 1227
2018
Q2 		$116K Buy
1,633
+125
+8% +$10.5K 0.01% 1441
2018
Q1 		$157K Hold
1,508
– – 0.01% 1208
2017
Q4 		$152K Buy
1,508
+1,088
+259% +$80.1K 0.01% 1248
2017
Q3 		$11K Hold
420
– – ﹤0.01% 2727
2017
Q2 		$10K Hold
420
– – ﹤0.01% 2805
2017
Q1 		$12K Buy
+420
New +$9.78K ﹤0.01% 2629

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Ameritas Investment Partners's ANAB Position: Q2 2026 in Review

Ameritas Investment Partners increased its AnaptysBio (ANAB) stake by 20% in Q2 2026, buying an estimated $18.1K and bringing the position to 1,793 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #1704.

Ameritas Investment Partners first reported a position in ANAB in Q1 2017 and has held it in 38 quarters since. The position peaked at $163K in Q3 2018. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Ameritas Investment Partners held 1,793 shares of AnaptysBio worth $121K as of Q2 2026.
  • Ameritas Investment Partners bought 299 AnaptysBio shares in Q2 2026, an estimated $18.1K.
  • AnaptysBio made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1704 holding.
  • Ameritas Investment Partners first reported a position in AnaptysBio in Q1 2017 and has held it in 38 quarters since.
  • Ameritas Investment Partners's AnaptysBio position peaked at $163K in Q3 2018.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.